These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 24663402)

  • 1. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.
    Kumarswamy R; Bauters C; Volkmann I; Maury F; Fetisch J; Holzmann A; Lemesle G; de Groote P; Pinet F; Thum T
    Circ Res; 2014 May; 114(10):1569-75. PubMed ID: 24663402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease.
    Santer L; López B; Ravassa S; Baer C; Riedel I; Chatterjee S; Moreno MU; González A; Querejeta R; Pinet F; Thum T; Díez J
    Hypertension; 2019 Apr; 73(4):820-828. PubMed ID: 30686085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Long Noncoding RNA LIPCAR Acts as a Novel Biomarker in Patients with ST-Segment Elevation Myocardial Infarction.
    Li M; Wang YF; Yang XC; Xu L; Li WM; Xia K; Zhang DP; Wu RN; Gan T
    Med Sci Monit; 2018 Jul; 24():5064-5070. PubMed ID: 30030914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating LIPCAR is a potential biomarker of heart failure in patients post-acute myocardial infarction.
    Yan L; Zhang Y; Wang M; Wang L; Zhang W; Ge ZR
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2589-2594. PubMed ID: 34365838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential of non-coding RNA as biomarkers in heart failure].
    Pinet F; Bauters C
    Med Sci (Paris); 2015; 31(8-9):770-6. PubMed ID: 26340837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction.
    Turkieh A; Beseme O; Saura O; Charrier H; Michel JB; Amouyel P; Thum T; Bauters C; Pinet F
    J Transl Med; 2024 Jan; 22(1):31. PubMed ID: 38184604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial.
    Meessen JMTA; Bär C; di Dona FM; Staszewsky LI; Di Giulio P; Di Tano G; Costa A; Leonardy J; Novelli D; Nicolis EB; Masson S; Pinet F; Thum T; Latini R
    Clin Chem; 2021 Nov; 67(12):1721-1731. PubMed ID: 34751777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.
    Zhang Z; Gao W; Long QQ; Zhang J; Li YF; Liu DC; Yan JJ; Yang ZJ; Wang LS
    Sci Rep; 2017 Aug; 7(1):7491. PubMed ID: 28790415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
    Iraqi W; Rossignol P; Angioi M; Fay R; Nuée J; Ketelslegers JM; Vincent J; Pitt B; Zannad F
    Circulation; 2009 May; 119(18):2471-9. PubMed ID: 19398668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus.
    Lamblin N; Fertin M; de Groote P; Bauters C
    J Cardiovasc Med (Hagerstown); 2012 Jun; 13(6):353-9. PubMed ID: 22498999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes.
    de Gonzalo-Calvo D; Kenneweg F; Bang C; Toro R; van der Meer RW; Rijzewijk LJ; Smit JW; Lamb HJ; Llorente-Cortes V; Thum T
    Sci Rep; 2016 Nov; 6():37354. PubMed ID: 27874027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIPCAR: a mitochondrial lnc in the noncoding RNA chain?
    Dorn GW
    Circ Res; 2014 May; 114(10):1548-50. PubMed ID: 24812345
    [No Abstract]   [Full Text] [Related]  

  • 14. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure.
    Richter B; Koller L; Hohensinner PJ; Zorn G; Brekalo M; Berger R; Mörtl D; Maurer G; Pacher R; Huber K; Wojta J; Hülsmann M; Niessner A
    Int J Cardiol; 2013 Sep; 168(2):1251-7. PubMed ID: 23218577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.
    Lopez-Andrès N; Rossignol P; Iraqi W; Fay R; Nuée J; Ghio S; Cleland JG; Zannad F; Lacolley P
    Eur J Heart Fail; 2012 Jan; 14(1):74-81. PubMed ID: 22089058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early expressed circulating long noncoding RNA CHAST is associated with cardiac contractile function in patients with acute myocardial infarction.
    Wang X; Wang L; Ma Z; Liang W; Li J; Li Y; Gui Y; Ai S
    Int J Cardiol; 2020 Mar; 302():15-20. PubMed ID: 31924400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial long noncoding RNAs as blood based biomarkers for cardiac remodeling in patients with hypertrophic cardiomyopathy.
    Kitow J; Derda AA; Beermann J; Kumarswarmy R; Pfanne A; Fendrich J; Lorenzen JM; Xiao K; Bavendiek U; Bauersachs J; Thum T
    Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H707-12. PubMed ID: 27422984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
    Fujimoto N; Onishi K; Sato A; Terasaki F; Tsukada B; Nozato T; Yamada T; Imanaka-Yoshida K; Yoshida T; Ito M; Hiroe M
    J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered long noncoding RNA expression profiles in the myocardium of rats with ischemic heart failure.
    Gao W; Wang ZM; Zhu M; Lian XQ; Zhao H; Zhao D; Yang ZJ; Lu X; Wang LS
    J Cardiovasc Med (Hagerstown); 2015 Jul; 16(7):473-9. PubMed ID: 26002832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium contributes to myocardial injury and cardiac remodeling in heart failure.
    Alexanian I; Parissis J; Farmakis D; Pantziou C; Ikonomidis I; Paraskevaidis I; Ioannidou S; Sideris A; Kremastinos D; Lekakis J; Filippatos G
    Int J Cardiol; 2014 Sep; 176(1):272-3. PubMed ID: 25042657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.